Responses
Drug information (i. anti-infectives, ii. cytostatics, iii. others)
DGI-035 Evaluation of the Systemic Toxicity of Doxorubicin After Hepatic Iodized Oil Chemoembolization in Hepatocellular Carcinoma Patients
Compose a Response to This Article
Other responses
No responses have been published for this article.